| SESSION I: INNOVATION FOR BETTER OUTCOME Chairs: Levent Çelik & Necati Özen |
|
| 08:30-08:45 |
Artificial intelligence for breast imaging: How far have we come? Speaker: Nico Karssemeijer |
| 08:45-09:00 |
Breast shape analysis for outcome after breast reconstruction Speaker: Giuseppe Catanuto |
| 09:00-09:15 |
Augmented reality to guide breast surgery Speaker: Pedro F. Gouveia |
| 09:15-09:30 |
Patient avatars: Virtual reality for surgeons Speaker: Fabien Reyal |
| 09:30-09:45 |
Deep-learning for precision medicine: Promises & limitations Speaker: Andreas Boss |
| 09:45-10:00 | Discussion / Q&A |
| 10:00-10:30 | COFFEE BREAK |
| SESSION IV: RECONSTRUCTION & RADIOTHERAPY Chairs: Nuran Beşe & Burcu Çelet Özden |
|
| 10:30-10:50 |
Defining surgical standards for conserving mastectomies Speaker: Yazan Masannat |
| 10:50-11:10 |
Defining standards for reconstructed chest wall irradiation Speaker: Philip Poortmans |
| 11:10-11:30 | Challenges for radiation oncologist after BCS: How to define the boost/APBI volume for reconstructed versus non-reconstructed breast Speaker: Atif Khan |
| 11:30-11:50 |
Immediate reconstruction in the previously irradiated breast: A safe algorithm to reduce complications Speaker: Fabien Reyal |
| 11:50-12:10 |
Technical modifications in implant-based reconstruction to improve outcome following PMRT Speaker: Maurizio Nava |
| 12:10-12:30 | Discussion / Q&A |
| 12:30-13:30 | LUNCH |
| 13:30-14:15 | SATELLITE SYMPOSIUM  Structured breast implant selection: Introducing the Mentor Breast Implant Selection Hub |
| 14:15-15:00 |
SATELLITE SYMPOSIUM Clinical and molecular perspectives in HR+ HER2- advanced breast cancer treatment: Valamor & Pimreva |
| SESSION VII: LONG-TERM IMPLANT-BASED RECONSTRUCTION COMPLICATIONS Chairs: Şükrü Yazar & Erdem Güven |
|
| 15:00-15:15 |
How to manage excess skin and NAC in implant-based breast reconstruction: A safe algorithm to reduce complications Speaker: Maurizio Nava |
| 15:15-15:30 | Management of infected breast implants Speaker: Farid Meybodi |
| 15:30-15:45 | How to minimize complications in ADM/mesh-assisted breast reconstruction? Speaker: Yoav Barnea (Live video conference) |
| 15:45-16:00 | How to handle seroma Speaker: Burcu Celet Ozden |
| 16:00-16:15 | Secondary breast implant surgery: What's new? Speaker: Marc Pacifico (Live video conference) |
| 16:15-16:30 | En-bloc capsulectomy and explantation: Patient selection; When and why? Speaker: Yoav Barnea (Live video conference) |
| 16:30-16:45 | Scientific Committee on Health, Environment and Emerging Risks (SCHEER) Statement on Safety of Breast Implants in Relation to ALCL: Personal comments Speaker: Moustapha Hamdi (Live video conference) |
| 16:45-17:00 | Discussion / Q&A |
| 17:00-17:30 | COFFEE BREAK |
| SESSION X: AUTOLOGOUS RECONSTRUCTIVE SURGERY Chairs: Sühan Ayhan & Serhan Tuncer |
|
| 17:30-17:45 | Therapeutic mammaplasty: The plastic surgeon's view Speaker: Albert Losken |
| 17:45-18:00 | Correction of late volumetric defects after BCS Speaker: Moustapha Hamdi (Live video conference) |
| 18:00-18:15 | Second choice after DIEP flap loss Speaker: Chris Andree |
| 18:15-18:30 | Prophylactic LV bypass with immediate breast reconstruction Speaker: Jaume Masia |
| 18:30-18:45 | Immediate-delayed autologous (IDEAL) breast reconstruction with DIEP flap Speaker: Chris Andree |
| 18:45-19:00 | Sensate breast reconstruction with innervated flaps: Myth or reality? Speaker: Jaume Masia |
| 19:00-19:15 | Discussion / Q&A |
| SESSION II: SYSTEMIC TREATMENT IN EARLY DISEASE Chairs: Adnan Aydıner & İdris Yücel |
|
| 08:30-08:45 |
Life without genomic classifiers: Who deserves adjuvant chemotherapy? |
| 08:45-09:00 |
Estimating risk of recurrence in early disease: Did genomic classifiers solve the whole puzzle? Speaker: Devrim Çabuk |
| 09:00-09:15 |
Who should get extended adjuvant endocrine treatment? Speaker: Özge Gümüşay |
| 09:15-09:30 |
Adjuvant CDK inhibitors: Ready for prime time? Speaker: Guiseppe Curigliano |
| 09:30-10:00 | Discussion / Q&A |
| 10:00-10:30 | COFFEE BREAK |
|
SESSION V: EARLY DISEASE |
|
| 10:30-10:40 |
Emerging role of biomarkers in early stage disease |
| 10:40-10:50 | Advances in intraoperative radiotherapy Speaker: Jayant Vaidya |
| 10:50 -12:30 | CASE PANEL: Navigating early stage HR+ disease with emerging data from genomic predictors Panelists: Guiseppe Curigliano, Selçuk Şeber, Peter Dubsky, Jayant Vaidya, Zerrin Calay, Senem Alanyalı, Ayşenur Alfatlı |
| 12:30-13:30 | LUNCH |
| 13:30-14:15 | SATELLITE SYMPOSIUM  Chair: Fatma Tokat Prosigna Update: The importance of molecular subytpes Speakers: Kelly Marcom, Fatma Tokat, Ahmet Sezer |
| 14:15-15:00 | SATELLITE SYMPOSIUM  Clinical utility of comprehensive liquid biopsy in advanced Breast Cancer Speaker: De Silva Minor |
| SESSION VIII: DCIS Chairs: Abut Kebudi & Merdan Fayda |
|
| 15:00-15:15 |
Unorthodox approach for DCIS Speaker: Fiona Gilbert |
| 15:15-15:30 |
Extent of surgery for DCIS Speaker: Shawna Willey |
| 15:30-15:45 |
Individualizing radiotherapy for DCIS Speaker: Gül Alço |
| 15:45-16:00 |
Magnitute of clinical benefit with endocrine treatment: Who should be treated? Speaker: Sevilay Altıntaş |
| 16:00-16:15 | Discussion / Q&A |
| 16:15-17:00 |
Case Panel: Multidisciplanary approach for patients with DCIS and LCIS Moderator: Omar Z. Youssef Panelists: Sevilay Altıntaş, Fiona Gilbert, Sıtkı Tuzlalı, Gül Alço, Shawna Willey |
| 17:00-17:30 | COFFEE BREAK |
| SESSION XI: HER2+ DISEASE Chairs: Nil Molinas Mandel & Handan Onur Topuzlu |
|
| 17:30-17:50 |
Unresolved issues in HER2 testing Speaker: Fatma Tokat |
| 17:50-18:10 |
Crossing the line: De-escalation and undertreatment Speaker: Gül Başaran |
| 18:10-18:30 |
De-escalation strategies for radiotherapy in HER2+ patients Speaker: Evrim Tezcanlı Tjon A Meeuw |
| 18:30-18:50 |
New treatment landscape in metastatic HER2+ breast cancer Speaker: Rupert Bartsch (Live video conference) |
| 18:50-19:05 | Discussion / Q&A |
| SESSION III: METASTATIC BREAST CANCER: MANAGEMENT OF ADVANCED DISEASE Chairs: Gülbeyaz Can & Necdet Üskent |
|
| 08:30-08:50 |
Care planning in advanced disease Speaker: Şeref Kömürcü |
| 08:50-09:10 |
Clinical trials in advanced disease Speaker: Burcu Çakar |
| 09:10-09:30 |
Role of breast nurse in advanced disease Speaker: Claire Ryan |
| 09:30-09:50 |
Good clinical practices: The real world experience Speaker: Claire Ryan |
| 09:50-10:00 | Discussion / Q&A |
| 10:00-10:30 | COFFEE BREAK |
| SESSION VI: METASTATIC BREAST CANCER: SUPPORTIVE MEASURE Chairs: Özgül Karayurt & M. Ümit Uğurlu |
|
| 10:30-10:55 |
End of life care: When and how to implement? Speaker: Rosalyn Yates |
| 10:55-11:20 |
Nutrition in advanced disease Speaker: Dilşat Baş |
| 11:20-11:45 |
Different perspectives: Family members and caregivers Speaker: Berna Sabrioğlu |
| 11:45-12:10 | Increasing awareness for advanced disease: Global studies and societies Speaker: Sema Erdem |
| 12:10-12:30 | Discussion / Q&A |
| 12:30-13:30 | LUNCH |
| 13:30-14:15 | SATELLITE SYMPOSIUM  Decision-making impact of OncotypeDx in hormone receptor positive/HER2 negative early BC: Real life stories |
| 14:15-15:00 | FREE TIME |
|
SESSION IX: METASTATIC BREAST CANCER: 360° APPROACH Moderator: Kemal Kuşçu |
|
| 15:00-16:00 |
Panel: Holistic approach to metastatic breast cancer |
| 16:00-17:00 |
PANEL: Complementary therapies in breast cancer: Yes or No Moderator: Gülbeyaz Can Panelists: Vildan Kocatepe, Dilek Yıldırım |
| 17:00-17:30 | COFFEE BREAK |
| SESSION XIII: NURSING CARE IN RARE SITUATIONS OF BREAST CANCER Chairs: Sevil Güler & Tamer Karşıdağ |
|
| 17:30-17:50 |
Breast cancer in male Speaker: Sema Koçan |
| 17:50-18:10 |
Breast cancer in pregnancy Speaker: Yasemin Nazlı |
| 18:10-18:30 |
Breast cancer in elderly Speaker: Arzu Tuna |
| 18:30-18:50 |
Breast cancer in very young patient |
| 18:50-19:05 | Discussion / Q&A |
| EARLY BIRD BREAKFAST SESSION | |
| 07:30 - 08:30 | How to get your paper published? Moderators: Kerstin Sandelin & Vahit Özmen |
| 08:30 - 12:30 | FREE TIME |
| 12:30 - 13:30 | LUNCH |
| 13:30 - 15:00 | FREE TIME |
| SESSION: FREE PAPERS Chairs: Aykut Soyder & Mehmet Sağır |
|
| 15:00 - 15:15 | Post-mastectomy chest wall defects: More than a single solution Presenter: Mahmoud A Alhussini |
| 15:15 - 15:30 | Tailoring the nipple-areolar complex pedicle for reduction mammoplasty - individualising patient care and safety Presenter: Peter Andrew Barry |
| 15:30 - 15:45 | Hatchet design rotation flaps for central, lower central complex partial breast defects after breast conservation surgery Presenter: Shalaka Joshi |
| 15:45 - 16:00 | The use of artificial intelligence for pre-op marking in oncoplastic breast surgery Presenter: Azadeh Joulaee |
| 16:00 - 16:15 | Transposition flap from lateral chest wall for outer half breast defects: A reliable alternative to LD and perforator-based flaps Presenter: Shalaka Joshi |
| 16:15 - 16:30 | Axillary management of breast cancer patients with isolated chest wall recurrence after mastectomy Presenter: Geok Hoon Lim |
| 16:30 - 16:45 | Intraoperative ultrasound-guided tailored axillary surgery after neoadjuvant therapy in node-negative breast cancer patients Presenter: Hakan Balbaloğlu |
| 16:45 - 17:00 | Use of axillary ultrasound-guided breast cancer management in the genomic assay era Presenter: Geok Hoon Lim |
| 17:00 - 17:30 | COFFEE BREAK |
| SESSION: FREE PAPERS Chairs: İbrahim Yıldız & Halil Kara |
|
| 17:30 - 17:45 | Linking gene expression and mutation to identify new therapy targets Presenter: Balazs Gyorffy |
| 17:45 - 18:00 | Fat loss solutions for overweight breast cancer patients with sleep disturbances Presenter: Diana Artene |
| 18:00 - 18:15 | Demographic and clinical features of patients with metastatic breast cancer: A retrospective multicenter registry study of the Turkish Oncology Group Presenter: İzzet Doğan |
| 18:15 - 18:30 | The increased creatinine level secondary to use of CDK 4/6 inhibitor and endocrine therapy: Real-life data Presenter: Merve Keskinkilic |
| 18:30 - 18:45 | The role of next-generation sequencing in the examination of breast cancer genetics in BRCA1/2-negative cases Presenter: Nuh Zafer Canturk |
| 18:45 - 19:00 | Adjuvant endocrine therapy adherence and affecting factors in breast cancer survivors Presenter: Yasemin Uslu |
| SESSION XIII: NEOADJUVANT TREATMENT-1 Chairs: Ertuğrul Gazioğlu & Fuat Demirelli |
|
| 08:30-08:45 |
Is it possible to omit chemotherapy in HR+ early breast cancer? Speaker: Sana Al-Sukhun |
| 08:45-09:00 |
Controversies in neoadjuvant systemic treatment of triple negative cancer patients with early disease Speaker: Sibylle Loibl |
| 09:00-09:15 |
Preoperative radiation therapy: To whom and when? Speaker: Philip Poortmans |
| 09:15-09:30 |
Defining & identifying complete response with imaging Speaker: Eva Fallenberg |
| 09:30-09:45 |
De-escalation of surgery after NAC: Where are we now? Speaker: Peter Dubsky |
| 09:45-10:00 | Discussion / Q&A |
| 10:00-10:30 | DEBATE Chairs: Mahmut Müslümanoğlu &Mustafa Tükenmez |
| 10:00-10:10 |
Axillary dissection should be standard for all ypN+ patients following NAC Speaker: Jayant Vaidya |
| 10:10-10:20 |
Axillary dissection should NOT be standard for all ypN+ patients following PST Speaker: Philip Poortmans |
| 10:20-10:30 | Discussion / Q&A |
| 10:30-11:00 | COFFEE BREAK |
|
SESSION XVI: PANEL Moderators: Taner Korkmaz, Gül Başaran &Varol Çelik |
|
| 11:00-12:30 | Case-based discussions on neoadjuvant treatment Panelists: Sibylle Loibl, Burcu Çakar, Senem Alanyalı, Ekrem Yavuz, Gül Esen İçten, Pedro Gouvea |
| 12:30-13:30 | LUNCH |
| 13:30-14:15 |
SATELLITE SYMPOSIUM |
| SESSION XX: ADVANCED DISEASE Chairs: Murat Dinçer & Gökhan Demir |
|
| 14:15-14:30 | Molecular tumor board in decision making: Not less, not more, just right Speaker: Erhan Gökmen |
| 14:30-14:45 |
The evolving role of CTC and cfDNA in the follow up of advanced breast cancer Speaker: Cemil Bilir |
| 14:45-15:05 | Managing resistance to endocrine treatment for metastatic disease in clinical practice Speaker: Leyla Özer |
| 15:05-15:25 | Changing landscape of metastatic triple negative breast cancer treatment Speaker: Hope Rugo |
| 15:25-15:45 | Ablative radiotherapy for oligometastatic disease and beyond Speaker: Anusheel Munshi |
| 15:45-16:15 | Discussion / Q&A |
| 16:15-16:45 | COFFEE BREAK |
| SESSION XXII: PANEL Moderators: Yeşim Eralp, Başak Oyan Uluç & Fatih Aydoğan |
|
| 16:45-18:15 |
TNBC in populations with limited resources; the role of local treatment in oligometastatic breast cancer |
| 18:30 - 18:45 | Closing ceremony and Awards |
| SESSION XIV: HIGH RISK WOMEN & PREVENTION Chairs: Pınar Saip, Zerrin Özgen & Mehmet Ali Gülçelik |
|
| 08:30-08:45 |
Clinical implications of hereditary panel testing beyond BRCA pathogenic variants in routine practice? Speaker: Banu Arun |
| 08:45-09:00 |
Radiotherapy for patients with germline high and moderate-risk pathogenic variants Speaker: Atif Khan |
| 09:00-09:15 |
Contralateral mastectomy versus breast conserving surgery in patients with mutations beyond BRCA Speaker: Kerstin Sandelin |
| 09:15-09:30 | Discussion / Q&A |
| PANEL: Moderator: Özlem Er & Yazan Masannat |
|
| 09:30-10:30 | Multidisciplanary approach for hereditary breast cancer and high risk mutation carriers Presenter: Murat Sarı Panelists: Banu Arun, Berna Öksüzoğlu, Atıf Khan, Ahmet Yeşilyurt, Kerstin Sandelin |
| 10:30-11:00 | COFFEE BREAK |
| SESSION XVII: HOW TO SCREEN PATIENTS WITH INCREASED RISK FOR BREAST CANCER Chairs: Gül Esen & Şebnem Orguç |
|
| 11:00-11:20 |
Risk stratification: Is it important? Speaker: Fiona Gilbert |
| 11:20-11:40 |
Adjunctive US screening: How and why? Speaker: Erkin Arıbal |
| 11:40-12:00 |
Contrast-enhanced mammography: Does it have a role? Speaker: Eva Fallenberg |
| 12:00-12:20 |
MRI screeening in the post-DENSE era: Why, who, when? Speaker: Fiona Gilbert |
| 12:20-12:30 | Discussion / Q&A |
| 12:30-13:30 | LUNCH |
| 13:30-14:15 | SATELLITE SYMPOSIUM  Latest trends and practices in biopsy and lesion localization Speaker: Erkin Arıbal |
| SESSION XXI: LOCO-REGIONAL TREATMENT IN EARLY DISEASE Chairs: Seher Demirer & Didem Çolpan Öksüz |
|
| 14:15-14:30 |
Targeted axillary dissection: The new standard for axillary management? Speaker: Michael Knauer |
| 14:30-14:45 |
Radiotherapy for patients with minimal axillary lymph node involvement (Nmic/N1) Speaker: Atif Khan |
| 14:45-15:00 |
Accelerated partial breast irradiation for low-risk breast cancer patients Speaker: Anusheel Munshi |
| 15:00-15:15 | Discussion / Q&A |
| 15:15-16:15 | DEBATE Chairs: Vahit Özmen, Nuran Beşe |
| 15:15-15:25 | Conventional fractionation should be used in breast cancer treatment Speaker: Ferah Yıldız |
| 15:25-15:35 | Conventional fractionation should NO LONGER be used in breast cancer treatment Speaker: Philip Poortmans |
| 15:35-15:45 | Discussion / Q&A |
| 15:45-15:55 | Conserving mastectomy is absolutely safe for breast cancer patients Speaker: Nicola Rocco |
| 15:55-16:05 | Conserving mastectomy is NOT safe for breast cancer patients Speaker: Orit Person |
| 16:05-16:15 | Discussion / Q&A |
| 16:15-16:45 | COFFEE BREAK |
| SESSION: FREE PAPERS Chairs: Mehmet Velidedeoğlu & Sibel Kul |
|
| 16:45-17:00 | The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after endocrine therapy Presenter: Gizem Oner |
| 17:00-17:15 | The increased creatinine level secondary to use of CDK 4/6 inhibitor and endocrine therapy: Real-life data Presenter: Merve Keskinkilic |
| 17:15-17:30 | A randomized clinical trial: The effects of preoperative protein restricted diet and physical activity on tumor characteristics and progression of early breast cancers Presenter: Nuh Zafer Cantürk |
| 17:30-17:45 | The role of shearwave elastography in prediction of tumor infiltrating lymphocyte rate in breast cancer Presenter: Yasemin Kayadibi |
| 17:45-18:00 | The effectiveness of the artificial intelligence on discriminating benign and malignant lesions on mammography Presenter: Ismail Tırnova |
| 18:00-18:15 | Diagnostic accuracy of transpara artificial intelligence system for histopathological subtypes, lesion size and receptor properties of breast cancer: A single center study Presenter: Omer Ozçağlayan |
| SESSION XV: SURVIVORSHIP – I Chair: Ükke Karabacak & Onur Dülgeroğlu |
|
| 08:30-08:45 | Use and impact of breast cancer survivorship care plans Speaker: Yasemin Uslu |
| 08:45-09:00 |
Antihormone therapies and management of adverse effects Speaker: Mustafa Bozkurt |
| 09:00-09:15 |
Genetic counseling for patients and family members Speaker: Maria Noblet |
| 09:15-09:30 |
Lymphedema Speaker: Menekşe Özgür İnbat |
| 09:30-10:30 | Discussion / Q&A |
| 10:30-11:00 | COFFEE BREAK |
| SESSION XVIII: SURVIVORSHIP – II Chairs: Cem Yılmaz |
|
| 11:00-11:20 | Nutrition in survivor patient Speaker: Evrim Tezcanlı Tjon A Meeuw |
| 11:20-11:40 | Pregnancy in Survivor patient Speaker: Selin Özaltın |
| 11:40-12:00 |
Body image and changing roles Speaker: Duygu Hiçdurmaz |
| 12:00-12:20 |
Survivorship: Patient experience Speaker: İnci Gültekin |
| 12:20-12:30 | Discussion / Q&A |
| 12:30-13:30 | LUNCH |
|
SESSION XIX: NGOS AND INTERNATIONAL SOLIDARITY |
|
| 13:30 - 14:10 | The power of international networks Speaker: Krisztina Toth (Live video conference) |
| 14:10 - 14:30 | From Turkey to Europe: International network experience Speaker: Yeşim Tuncer |
| 14:30-15:00 | COFFEE BREAK |
| SESSION XXII: PROCESSES, SOLUTIONS AND PROJECTS PRODUCED BY CANCER PATIENTS AND NGOS DURING THE PANDEMIC IN TURKEY Chair: Seral Celik |
|
| 15:00 - 15:20 | Individuals living with cancer in Turkey and the Covid-19 pandemic research Speaker: Gurkan Sert |
| 15:20 - 15:40 | ONKOVAN from the perspective of patient rights during the pandemic process experience Speaker: Aslı Ortakmac |
| 15:40-16:00 | Be a hero / live Speaker: Dida Kaymaz |
| 16:00-16:30 | COFFEE BREAK |
| SESSION XXV: ROUNDTABLE MEETING Synergy: Getting Stronger Together Chairperson: Fisun Önen Participants: Cancer Fighters Association, Cancer Control Association, Europa Donna Turkey, Uludag Oncology Solidarity Association, Hope And Life Association, Cancer-Free Life Association, Turkish Cancer Association, Dance With the Cancer, Young Savings Association,Metamazon Metastatic Breast Cancer Association, Society for Breast Health, Turkish Society of Medical Oncology, Turkish Society of Surgery, Turkish Society of Oncology Nursing |
| EARLY-BIRD CRITICAL-THINKING SESSION Moderator: Ashutosh Kothari |
|
| 07:30-08:30 | Difficult surgery cases: How did I manage? Panelists: Atakan Sezer, Güldeniz Karadeniz Çakmak & Anand Koppiker |
| 08:30-10:00 | COFFEE BREAK |
| 10:00-11:00 | FREE TIME |
| SESSION: FREE PAPERS Chairs: Ayfer Ay Eren & Ayşegül Gemici |
|
| 11:00-11:15 | Performance of radiologists when interpreting breast screening mammography: A study from the Middle East Presenter: Mohammad A Rawashdeh |
| 11:15-11:30 | Contributions of AI in the daily workflow of a breast imaging clinic Presenter: Damla Su Aydın |
| 11:30-11:45 | Clinical and pathological characteristics of AI-missed cancers Presenter: Mustafa Ege Seker |
| 11:45-12:00 | Comparison of automated breast ultrasound and hand-held ultrasound regarding time savings and operational costs in the workflow of a breast clinic Presenter: Sila Ulus |
| 12:00-12:15 | Estimating the skin flap thickness with breast MRI: A case series of 438 skin and nipple-sparing mastectomies with implant reconstructions Presenter: Cem Osman Yilmaz |
| 12:15-12:30 | Analysis of skin flap thickness after skin-sparing and nipple-sparing mastectomy Presenter: Seda Eröz |
| 12:30-13:30 | LUNCH |
| 13:00-11:00 | FREE TIME |
| SESSION: FREE PAPERS Chairs: Aziz Yazar & Faysal Dane |
|
| 14:15-14:30 | Pushing the limits of breast conservation therapy with extreme oncoplasty: Requires good planning and collaboration Presenter: Berkay Kılıç |
| 14:30-14:45 | Prognostic factors affecting survival in early stage unifocal Luminal B human epidermal growth factor 2-negative and triple negative breast cancers Presenter: Ekrem Ferlengez |
| 14:45-15:00 | Direct-to-implant reconstruction with tutopatch in 391 breasts Presenter: Mehmet Sağır |
| 15:00-15:15 | Immunotherapy experience in patients with breast cancer: A single-center experience Presenter: Feride Yılmaz |
| 15:15-15:30 | Impact of oncotype DX recurrence score on clinical outcome: Single center real-life experience with median 87 months follow up Presenter: Gul Basaran Basaran |
| 15:30-15:45 | The relationship between mamographic density and pathological response in patients with local advanced breast cancer receiving neoadjuvan chemotherapy Presenter: Eda Calıskan Yıldırım |
| 15:45-16:45 | COFFEE BREAK |
| 16:45-18:15 | FREE TIME |
| Course Directors: Omar Z. Youssef, Bahadir M. Gulluoglu & Cihan Uras | |
| 08:00-12:00 | Opening Addressers: Kerstin Sandelin & Bahadir M. Gulluoglu LIVE SURGERY Moderator (at the Auditorium): Shawna Willey Moderator (at the Theatre): Hasan Karanlik Surgeons/Tutors: Farid Meybodi, Omar Z. Youssef, Cihan Uras, Halil Kara & A. Enes Arıkan Case at Theatre 1: SSM/NSM with subpectoral/prepectoral implant reconstruction with or without meshes/ADMs Case at Theatre 2: Therapeutic mammoplasty/ Perforator flap |
| 12:00-12:45 | LUNCH |
| INDUSTRIAL SPONSORED LECTURE: What we learned after 1450 adm-assisted prepectoral breast reconstructions Chair: Cihan Uras Speaker: Enrico Vigato |
|
| SESSION I: THE SURGICAL ART BEHIND BREAST IMPLANTS Chairs: Ali Ilker Filiz & Kerstin Sandelin |
|
| 13:00-13:15 |
Prepectoral versus subpectoral breast implant reconstruction; who wins? Speaker: Maurizio Nava |
| 13:15-13:30 |
Implant-based breast reconstruction: Surgeon & patient perspectives Speaker: Yazan Masannat |
| 13:30-13:45 |
How to optimize aesthetic outcomes in implant-based breast reconstruction Speaker: Giuseppe Catanuto |
| 13:45-14:00 |
Nipple sparing mastectomy and implant reconstruction in large and ptotic breast Speaker: Farid Meybodi |
| 14:00-14:30 | Discussion / Q&A |
| 14:30-15:00 | COFFEE BREAK |
| LECTURE II: WHEN EXPERIENCE MATTERS FOR OUTCOME Chairs: Sibel Ozkan Gurdal & Shawna Willey |
|
| 15:00-15:15 |
Extreme oncoplasty: The alternative path Speaker: Omar Z. Youssef |
| 15:15-15:30 |
Tips & tricks during nipple-areola sparing mastectomy Speaker: Shawna Willey |
| 15:30-15:45 |
Managing complications Speaker: Nicola Rocco |
| 15:45-16:00 |
Towards standardization of oncoplastic surgery training; Future perspectives Speaker: Kerstin Sandelin |
| 16:00-16:30 | Discussion / Q&A |
| 16:30-16:45 | Remarks & Adjourn Addressers: Omar Z. Youssef & Bahadir M. Gulluoglu |
| Course Directors: Gul Esen Icten & Fahrettin Kılıç | |
| SESSION I: WHAT IS THE CONTRIBUTION OF AI IN THE REAL WORLD? Moderator: Gul Esen Icten |
|
| 09:15-09:20 | Opening |
| 09:20-09:40 |
Role of Al in mammography and tomosynthesis |
| 09:40-10:00 |
Case-based review of AI in mammography |
| 10:00-10:20 |
Case-based review of AI in ultrasound |
| 10:20-10:30 | Discussion / Q&A |
| 10:30-11:00 | COFFEE BREAK |
|
SESSION II: CONTRAST ENHANCED MAMMOGRAPHY |
|
| 11:00-11:20 |
Technique, implementation, and interpretation |
| 11:20-11:40 |
Indications, advantages, and challenges |
| 11:40-12:10 |
Case-based review |
| 12:10-12:30 | Discussion: Will CESM take the place of MRI? |
| 12:30-14:00 | LUNCH |
|
SESSION III: MANAGEMENT OF NON-MASS LESIONS |
|
| 14:30-14:55 |
Non-mass lesions in mammography |
| 14:55-15:20 |
Non-mass lesions in US |
| 15:20-15:45 |
Non-mass lesions in MRI |
| 15:45-16:10 |
Radiologic-pathologic correlation in non-mass lesions |
| 16:10-16:30 | Discussion / Q&A |
| 16:30-17:00 | COFFEE BREAK |
|
LECTURE IV: RADIOLOGIC MANAGEMENT OF PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPHY |
|
| 17:00-17:20 |
How to prepare patients for therapy |
| 17:20-17:40 |
How to monitor treatment |
| 17:40-18:00 |
Case-based review of challenges in radiological evaluation |
| 18:00-18:05 | Closure |
| Course Directors: Maria Noblet, Claire Ryan, Ayla Gürsoy & Özgül Karayurt | |
| 09:15-09:30 |
WELCOME Housekeeping Speaker: Claire Ryan Chairs: Ayla Gürsoy, Claire Ryan |
|
SESSION I: PATIENT NAVIGATION AND COMMUNICATION |
|
| 09:30-10:30 | Navigating a breast cancer diagnosis Speaker: Maria Noblet |
| 10:30-11:15 | Communication between nurse and patient navigating a breast cancer diagnosis Speaker: Rosalyn Yates |
| 11:15-11:45 | COFFEE BREAK |
| SESSION II: BREAST CANCER DIAGNOSIS AND TREATMENT: THE ROLE OF NURSING Chairs: Özgül Karayurt & Maria Noblet |
|
| 11:45-12:30 | Navigating surgery and treatment Speaker: Claire Ryan |
| 12:30-13:00 | Discussion / Q&A |
| 13:00-14:30 | LUNCH |
| SESSION III A: LIVING WITH AND BEYOND CANCER - THE ROLE OF NURSING Chairs: Sevil Güler & Ayla Gürsoy |
|
| 14:30-15:30 | New ways of working with patients living with and beyond cancer Speaker: Maria Noblet |
| 15:30-16:15 | Interventions for consequences of treatment Speaker: Claire Ryan |
| 16:15-16:45 | COFFEE BREAK |
| SESSION III B: LIVING WITH AND BEYOND CANCER - THE ROLE OF NURSING Chairs: Sevil Güler & Ayla Gürsoy |
|
| 16-45-17:30 | Impact of caring for patients with cancer. How do we look after ourselves? Speaker: Rosalyn Yates |
| 17:30-18:00 | Closing remarks and summary of learnings for the day Speaker: Maria Noblet |
| Course Director: Uğur Özbek | |
| Chairs: Uğur Özbek & Nuri Karadurmuş | |
| 08:30 - 09:15 | Genetic Literacy: How should we read molecular genetic tests? Speaker: Ahmet Yeşilyurt |
| 09:15 - 09:30 | Discussion / Q&A |
| 09:30 - 10:15 | Genetic testing and management of patients with breast cancer: When and which? Speaker: Başak Oyan Uluç |
| 10:15 - 10:30 | Discussion / Q&A |
| 10:30 - 11:00 | COFFEE BREAK |
| Chairs: Uğur Özbek & Nuri Karadurmuş | |
| 11:00 - 11:30 | Comprehensive approach to patients with breast cancer through personalized genetic tests Speaker: Ahmet Yeşilyurt |
| 11:30 - 11:45 | Discussion / Q&A |
| 11:45 - 12:30 | Case discussion panel |
| 12:30-13:30 | LUNCH |
| OPENING CEREMONY | |
| 19:00-19:15 | Welcome Address Speaker: Cihan Uras |
| 19:15-20:00 |
Prof. Dr. Cemalettin Topuzlu Conference Speaker: Hope Rugo |
